Jang, A.S.; Kim, S.H.; Lee, S.P.; Na, M.J.; Yoo, K.H.; Park, C.H.; Park, S.Y.; Choi, B.W.
The Efficacy and Safety of Pelubiprofen in the Treatment of Acute Upper Respiratory Tract Infection: A Multicenter, Randomized, Double-Blind, Non-Inferiority Phase III Clinical Trial Compared to Loxoprofen. J. Clin. Med. 2025, 14, 1450.
https://doi.org/10.3390/jcm14051450
AMA Style
Jang AS, Kim SH, Lee SP, Na MJ, Yoo KH, Park CH, Park SY, Choi BW.
The Efficacy and Safety of Pelubiprofen in the Treatment of Acute Upper Respiratory Tract Infection: A Multicenter, Randomized, Double-Blind, Non-Inferiority Phase III Clinical Trial Compared to Loxoprofen. Journal of Clinical Medicine. 2025; 14(5):1450.
https://doi.org/10.3390/jcm14051450
Chicago/Turabian Style
Jang, An Soo, Sang Hoon Kim, Sang Pyo Lee, Moon Jun Na, Kwang Ha Yoo, Chang Han Park, Seong Yeon Park, and Byoung Whui Choi.
2025. "The Efficacy and Safety of Pelubiprofen in the Treatment of Acute Upper Respiratory Tract Infection: A Multicenter, Randomized, Double-Blind, Non-Inferiority Phase III Clinical Trial Compared to Loxoprofen" Journal of Clinical Medicine 14, no. 5: 1450.
https://doi.org/10.3390/jcm14051450
APA Style
Jang, A. S., Kim, S. H., Lee, S. P., Na, M. J., Yoo, K. H., Park, C. H., Park, S. Y., & Choi, B. W.
(2025). The Efficacy and Safety of Pelubiprofen in the Treatment of Acute Upper Respiratory Tract Infection: A Multicenter, Randomized, Double-Blind, Non-Inferiority Phase III Clinical Trial Compared to Loxoprofen. Journal of Clinical Medicine, 14(5), 1450.
https://doi.org/10.3390/jcm14051450
